secwatch / observer
8-K filed September 3, 2024, 7:59 PM ET ticker ZYME CIK 0001937653
leadership confidence high sentiment neutral materiality 0.50

Leone Patterson starts as CFO on Sept 1; Galbraith resigns as interim CFO but remains CEO/Chair

Zymeworks Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Leone Patterson

Executive Vice President, Chief Business Officer and Chief Financial Officer
ZYME · Zymeworks Inc.
Effective
2024-09-01
Filed
September 3, 2024, 7:59 PM ET
the Company’s board of directors (the “Board”) appointed Ms. Leone Patterson, age 61, as Executive Vice President, Chief Business Officer and Chief Financial Officer of the Company, effective upon her commencement of employment with the Company, which was anticipated to be September 1, 2024.
Departed (interim)

Kenneth Galbraith

interim Chief Financial Officer
ZYME · Zymeworks Inc.
Effective
2024-09-01
Successor
Leone Patterson
Filed
September 3, 2024, 7:59 PM ET
On August 30, 2024, Mr. Kenneth Galbraith resigned from the positions of interim Chief Financial Officer and as principal financial officer and principal accounting officer of the Company, effective as of the Start Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Leone Patterson was appointed as Executive Vice President, Chief Business Officer and Chief Financial Officer at Zymeworks Inc..

Action
appointed
Role
Executive Vice President, Chief Business Officer and Chief Financial Officer
Exact text from the filing
the Company’s board of directors (the “Board”) appointed Ms. Leone Patterson, age 61, as Executive Vice President, Chief Business Officer and Chief Financial Officer of the Company, effective upon her commencement of employment with the Company, which was anticipated to be September 1, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kenneth Galbraith resigned as interim Chief Financial Officer at Zymeworks Inc..

Action
resigned
Role
interim Chief Financial Officer
Exact text from the filing
On August 30, 2024, Mr. Kenneth Galbraith resigned from the positions of interim Chief Financial Officer and as principal financial officer and principal accounting officer of the Company, effective as of the Start Date.
View on SEC.gov

Zymeworks Inc. filing history →

Source: SEC EDGAR
accession 0001193125-24-212062
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.